Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)

Recruiting now

Conditions studied: Bronchiectasis Adult

In brief

The purpose of this study is to collect data to assess the use of the LibAirty™ System for improving bronchiectasis symptoms and healthcare resource utilization when it is used at home. The main question this study is trying to answer is: How often do adults with bronchiectasis experience pulmonary exacerbations (flare-ups of their lung condition) while using the LibAirty™ airway clearance system at home? Participants will use the LibAirty™ airway clearance system at home as prescribed by their doctor - the device is not being provided as part of the study. The study will last for 12 months from the time participants begin using LibAirty. During the study period, participants will continue with their usual clinic visits. At some of these regular visits (up to 4 times over the year), participants will be asked to complete short questionnaires about their bronchiectasis symptoms and their experience using LibAirty. At these same visits, the study team will also review participants' medical records and collect information related to their bronchiectasis condition, such as test results, medications, and any hospital or emergency room visits.

Key facts

Study ID

NCT07135284

Run by

Synchrony-Medical, Ltd

People needed

200

Starts

2025-08-20

Expected to finish

2027-02-01

Last updated by the study team

2026-04-13

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have a radiological diagnosis of Bronchiectasis based on high resolution chest CT scan
• Have bronchiectasis characterized by either:
• Daily productive cough (as determined by a treating physician)
• OR Available documentation from the last 12 months of 2 or more pulmonary exacerbations requiring antibiotic therapy
• Be at age ≥ 21 years
• Prescribed and receives the LibAirty system for home use
• Be on a standard of care treatment plan that includes at least one physician encounter every 6 months
• No change in treatment for Bronchiectasis in the 2-month period prior to enrollment
• Signed informed consent

You may not qualify if…

• Inability to independently perform therapy with the LibAirty system as directed
• Any other condition that, in the opinion of the PI, could jeopardize the safety of the subject or impact the validity of the study results.
• Pregnancy or planned pregnancy during the expected duration of the trial (12 months).

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)
• Emory University School Of Medicine — Atlanta, Georgia, United States (enrolling)
• Medical University of South Carolina — Charleston, South Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.